EPIVAC
EPIVAC (Epidemiology and Vaccines)
The EPIVAC Group (Epidemiology and Vaccines), accredited as a consolidated research group in the call SGR 2013 and reaccredited SGR 2017, conducts epidemiological and clinical research in vaccine-preventable infectious diseases of the respiratory system, especially cohort studies evaluating the effectiveness in practice of pneumococcal and influenza vaccinations from primary care. During 2017-2022 the group has carried out 3 research projects funded in competitive public calls (ISCIII and PERIS). The members of the group have directed 2 doctoral theses and have published (as first authors) more than 15 scientific articles in national and international biomedical journals, with a bibliometric impact factor exceeding 30 points. Some of the group's papers have been incorporated into the most recent updates of Cochrane reviews on the subject and have been used to establish recommendations in various clinical practice guidelines.
Group Projects
|
PI: Clua Espuny, Josep Lluis. L'abordatge del diagnòstic PREcoç de la Fibril·lació Auricular en pacients d'alt risc: estudi multicentric, prospectiu i randomitzat (PREFA-TE). Funding: Departament de Salut. Duration: 2022 - 2024 |
|
PI: Clua Espuny, Josep Lluis. L'abordatge del diagnòstic PREcoç de la Fibril·lació Auricular en pacients d'alt risc: estudi multicentric, prospectiu i randomitzat (PREFA-TE). Funding: Departament de Salut. Duration: 2022 - 2024 |
|
PI: Vila Corcoles, Angel. Efectividad clínica e impacto de la vacunación antineumocócica conjugada (VNC13) y/o polisacárida (VNP23) en adultos con distintas condiciones de riesgo: estudio de cohortes de base poblacional post introducción de la vacunación infantil universal con VNC13. Funding: Instituto de Salud Carlos III. Duration: 2021 - 2023 |
The group participates in the following projects
|
PI: Villalobos Martínez, Felipe. Post-Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID -19) Vaccine. Funding: Fondazione Penta ONLUS. Duration: 2021 - 2024 |
|
PI: Aragón Pérez, María. vACCine covid-19 monitoring readinESS (ACCESS). Funding: UMC Utrecht (University Medical Center Utrecht). Duration: 2020 - 2022 |
Group Publications
|
Satué Gracia EM, Vila Córcoles Á. [COVID-19 prognostic indicators in Primary Care]. Aten Primaria. 2022 Feb; 54(7):102308. doi:10.1016/j.aprim.2022.102308. Epub 2022 Feb 10. Spanish. pmc:PMC8828413. PMID:35306295. IF: 1,137. |
|
Satué-Gracia EM, Vila-Córcoles A, de Diego-Cabanes C, Vila-Rovira A, Torrente-Fraga C, Gómez-Bertomeu F, Hospital-Guardiola I, Ochoa-Gondar O, Martín-Luján F. Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain. Med Clin (Barc). 2022 03; 158(6):251-259. doi:10.1016/j.medcli.2021.03.027. Epub 2021 May 07. pmc:PMC8103142. PMID:34074472. IF: 1,725. |
|
Satué-Gracia EM, Vila-Córcoles A, de Diego-Cabanes C, Vila-Rovira A, Torrente-Fraga C, Gómez-Bertomeu F, Hospital-Guardiola I, Ochoa-Gondar O, Martín-Luján F. Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain. Med Clin (Engl Ed). 2022 Mar; 158(6):251-259. doi:10.1016/j.medcle.2021.03.034. Epub 2022 Apr 23. pmc:PMC9034652. PMID:35492428. IF: . |
|
Vila Córcoles Á. Pneumococcal vaccination in times of COVID-19. Med Clin (Barc). 2022 Apr; 158(8):366-368. doi:10.1016/j.medcli.2022.01.001. Epub 2022 Jan 21. pmc:PMC8776499. PMID:35177267. IF: 1,725. |
|
Vila Córcoles Á. Pneumococcal vaccination in times of COVID-19. Med Clin (Engl Ed). 2022 May; doi:10.1016/j.medcle.2022.01.004. Epub 2022 May 05. pmc:PMC9069305. PMID:35530263. IF: . |
The group participates in the following publications
|
Palà E, Bustamante A, Clúa-Espuny JL, Acosta J, González-Loyola F, Santos SD, Ribas-Segui D, Ballesta-Ors J, Penalba A, Giralt M, Lechuga-Duran I, Gentille-Lorente D, Pedrote A, Muñoz MÁ, Montaner J. Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study. PLoS One. 2022 ; 17(8):e0273571. doi:10.1371/journal.pone.0273571. Epub 2022 Aug 23. pmc:PMC9398023. PMID:35998199. IF: 3,240. |
|
Palà E, Bustamante A, Pagola J, Juega J, Francisco-Pascual J, Penalba A, Rodriguez M, De Lera Alfonso M, Arenillas JF, Cabezas JA, Pérez-Sánchez S, Moniche F, de Torres R, González-Alujas T, Clúa-Espuny JL, Ballesta-Ors J, Ribas D, Acosta J, Pedrote A, Gonzalez-Loyola F, Gentile Lorente D, Ángel Muñoz M, Molina CA, Montaner J. Blood-Based Biomarkers to Search for Atrial Fibrillation in High-Risk Asymptomatic Individuals and Cryptogenic Stroke Patients. Front Cardiovasc Med. 2022 ; 9:908053. doi:10.3389/fcvm.2022.908053. Epub 2022 Jul 04. pmc:PMC9289129. PMID:35859587. IF: 6,050. |
Indicators
|
Indicator |
2022 |
|---|---|
|
Researchers with PhD |
14 |
|
Total number of projects in which group members have participated |
6 |
|
Total number of projects in which the PI of the project has belonged to the group |
1 |
|
Total Funding |
597.401,08€ |
|
Scientific publications in indexed journals |
5 |
|
Total Impact factor |
13,88 |
|
Nº of articles in Q1 journals |
1 |
|
Q1 IF |
6,05 |
|
Nº of articles in Q2 journals |
1 |
|
Q2 IF |
3.24 |
